Rapid Covid-19 Antigen Test

The Rapid COVID-19 Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 through direct nasopharyngeal (NP) swab specimens directly collected from individuals who are suspected of having COVID-19 by their healthcare professional. This test is designed to assist in the rapid diagnosis of SARS-CoV-2 infections. The Rapid COVID-19 Antigen Test does not determine between SARS-CoV and SARS-CoV-2.

  • Highly specific, and selective for SARS-CoV-2 nucleocapsid protein

  • Simple, visual results within 15 minutes

  • Specimen Type: Direct Nasopharyngeal Swab*

  • No Instrumentation Required

  • Storage: 2-30°C

  • Stability: 2 years from date of manufacture

  • Controls available separately

For questions or pricing information please call us at (866) 788-2855

  • This test has not been reviewed by the FDA

  • Negative results do not rule out SARS-CoV-2 infection, particularly those who have been in contact with the virus. Follow up testing with a molecular diagnostic test should be considered to rule out infection in these individuals.

  • Use of this test is limited to laboratories certified to perform high complexity testing, including testing at point-of-care when the site is covered by the laboratory's CLIA certificate of high-complexity testing.

  • This test is not for home-use or at-home specimen collection.

FDA Resources: